MicroRNA-22 and promoter motif polymorphisms at the Chga locus in genetic hypertension: functional and therapeutic implications for gene expression and the pathogenesis of hypertension.
about
MicroRNAs and Endothelial (Dys) FunctionThe emerging role of non-coding RNA in essential hypertension and blood pressure regulation.microRNAs in Essential Hypertension and Blood Pressure Regulation.Non-coding RNAs in cardiac hypertrophy.miR-22 in cardiac remodeling and diseaseSignatures of natural selection at the FTO (fat mass and obesity associated) locus in human populations.Molecular Mechanism for Hypertensive Renal Disease: Differential Regulation of Chromogranin A Expression at 3'-Untranslated Region Polymorphism C+87T by MicroRNA-107Mechanisms and therapeutic potential of microRNAs in hypertension.Blood pressure and expression of microRNAs in whole bloodNon-coding RNAs and hypertension-unveiling unexpected mechanisms of hypertension by the dark matter of the genomeChromogranin A as a biomarker in cardiovascular disease.Analysis and validation of traits associated with a single nucleotide polymorphism Gly364Ser in catestatin using humanized chromogranin A mouse models.Phosphodiesterase-5 inhibition preserves renal hemodynamics and function in mice with diabetic kidney disease by modulating miR-22 and BMP7.MiR-664a-3p expression in patients with obstructive sleep apnea: A potential marker of atherosclerosis.Non-Coding RNA in the Pathogenesis, Progression and Treatment of Hypertension.
P2860
Q26775547-E3904A1E-0D1D-4A71-A78D-6FF02B315659Q33359407-6C28962F-DCCC-4A61-B4FA-547009F8E1ECQ33362101-FF391034-1C63-4360-96BC-FEE18EA2B08CQ33800147-A197E951-E4BA-43A6-84A5-B4AAAF71E6BBQ34225020-428EBD05-A855-4B44-A679-F3030DD18FF6Q35554357-51B5FF55-EABC-4D1B-8DAC-6112A35DFE53Q35903118-33021085-10EB-491E-8379-703EFB7E331BQ36173562-FC8029D4-BE3E-43F0-8B2D-C0C6DA7C2CE1Q36302398-A988F905-237F-4455-B3C9-37AD54ACF712Q37741539-B4AC738E-9AF1-419C-BA2B-3A5654BA828DQ38170143-3B03F872-B4C2-4F19-80CC-5E1FF0740DFAQ41590605-DDCC524F-8D5F-4E98-A02B-7A08EF6DE08FQ42125804-3FB78F91-B3AE-48EE-AA2D-575D691602D6Q50117861-691236B7-02C2-4506-BAA3-80037EAF475AQ52347947-6B06C3AF-0E23-4AB5-8E9F-D5A854DFDFFE
P2860
MicroRNA-22 and promoter motif polymorphisms at the Chga locus in genetic hypertension: functional and therapeutic implications for gene expression and the pathogenesis of hypertension.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 13 May 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
MicroRNA-22 and promoter motif ...... pathogenesis of hypertension.
@en
MicroRNA-22 and promoter motif ...... pathogenesis of hypertension.
@nl
type
label
MicroRNA-22 and promoter motif ...... pathogenesis of hypertension.
@en
MicroRNA-22 and promoter motif ...... pathogenesis of hypertension.
@nl
prefLabel
MicroRNA-22 and promoter motif ...... pathogenesis of hypertension.
@en
MicroRNA-22 and promoter motif ...... pathogenesis of hypertension.
@nl
P2093
P2860
P921
P356
P1476
MicroRNA-22 and promoter motif ...... e pathogenesis of hypertension
@en
P2093
Angelina E Altshuler
C Makena Hightower
Daniel T O'Connor
Geert W Schmid-Schönbein
Hyung-Suk Kim
Jiaur R Gayen
Jose Pablo Miramontes-Gonzalez
Kuixing Zhang
Laurent Taupenot
Martin L Jirout
P2860
P304
P356
10.1093/HMG/DDT213
P577
2013-05-13T00:00:00Z